HCA: From Public Company to Private Company, and Back Again

In 2006, we represented HCA Inc. in its $33 billion going-private recapitalization transaction with affiliates of Bain Capital, Kohlberg Kravis Roberts & Co. and Merrill Lynch Global Private Equity. This was the largest domestic leveraged buyout in history at the time.

In March 2011, we represented HCA Holdings, Inc. in the largest private-equity backed initial public offering (IPO) in U.S. history at that time. The shares began trading on the New York Stock Exchange (NYSE) on March 10. Following the IPO, HCA remained controlled by a private investor group comprised of affiliates of, or funds sponsored by, Bain Capital Partners LLC, Kohlberg Kravis Roberts & Co., BAML Capital Partners, Citigroup Inc., Bank of America Corporation and HCA founder, Dr. Thomas F. Frist, Jr.

We continue to provide corporate and securities as well as healthcare regulatory advice to HCA.

HCA Holdings, Inc. (NYSE: HCA) owns and operates hospitals and freestanding surgery centers in the U.S. and in London, England.

You Also May Be Interested In:

  • Representing the independent Special Committee of Strategic Storage Growth Trust, Inc. (SSGT), in its definitive agreement to merge with Strategic Storage Trust II, Inc., (SST II) in an all-cash merger valued at $340 million expected to close during the first quarter of 2019, subject to customary closing conditions, including the approval of SSGT’s stockholders

    We are representing the independent Special Committee of Strategic Storage Growth Trust, Inc. (SSGT), in its definitive agreement to merge...
    Client Type: Private Company
  • Represented Wright Medical Group in its acquisition of Cartiva, Inc.

    We served as lead counsel to Wright Medical Group N.V. (Nasdaq: WMGI) in the acquisition of Cartiva, Inc., a privately-held...
    Client Type: Public Company
  • We represented NN, Inc. (Nasdaq: NNBR) in its public offering of 14,375,000 shares of common stock, which was composed of...
    Client Type: Public Company